<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03489915</url>
  </required_header>
  <id_info>
    <org_study_id>cbtvaatoctpomestrvo</org_study_id>
    <nct_id>NCT03489915</nct_id>
  </id_info>
  <brief_title>Correlation Between the Visual Acuity &amp; the OCT Pattern of Macular Edema Secondary to RVO</brief_title>
  <official_title>Correlation Between the Visual Acuity and the OCT Pattern of Macular Edema Secondary to Retinal Vein Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Correlation between changes observed in OCT and VA in patients with retinal vein occlusion
      whether the patient's VA improves when macular edema improves in OCT or not ??
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Central retinal vein occlusion (CRVO) is a common retinal vascular disorder. Clinically, CRVO
      presents with variable visual loss; fundus may show retinal hemorrhages, dilated tortuous
      retinal veins, cotton-wool spots, macular edIn view of the devastating complications
      associated with the severe form of CRVO, number of classifications were described. All of
      classifications take into account the area of retinal capillary nonperfusion and development
      of neovascular complications.

      CRVO can be divided into 2 clinical types, ischemic and nonischemic. In addition, a number of
      patients may have an intermediate presentation with variable clinical course. On initial
      presentation, it may be difficult to classify a given patient, since CRVO may change with
      time.

      A number of clinical and ancillary investigative factors are taken into account for
      classifying CRVO:

      Nonischemic CRVO is milder form of disease. It may present with good vision, few retinal
      hemorrhages and cotton-wool spots, no relative afferent pupillary defect, and good perfusion
      to the retina. Nonischemic CRVO may resolve fully with good visual outcome or may progress to
      the ischemic type.

      Ischemic CRVO is the severe form of the disease. CRVO may present initially as the ischemic
      type, or it may progress from nonischemic. Usually, ischemic CRVO presents with severe visual
      loss, extensive retinal hemorrhages and cotton-wool spots, presence of relative afferent
      pupillary defect, poor perfusion to retina, and presence of severe electroretinographic
      changes. In addition, patients may end up with neovascular glaucoma and a painful blind eye.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Macular edema assessment</measure>
    <time_frame>5 minutes</time_frame>
    <description>Macular edema assessed by OCT in microns</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual acuity assessment</measure>
    <time_frame>5 minutes</time_frame>
    <description>Visual acuity assessment through Landolt chart</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Causes of non improvement of visual acuity in patients with resolving macular edema</measure>
    <time_frame>5 minutes</time_frame>
    <description>To detect causes of visual non improvement with visual acuity measured through Landolt chart in patients with resolving macular edema measured by OCT device in microns</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Retinal Vein Occlusion</condition>
  <arm_group>
    <arm_group_label>Patients with macular edema due to RVO</arm_group_label>
    <description>assessment of visual acuity using Landolt chart and follow up of macular edema using OCT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCT</intervention_name>
    <description>Assessment of macular edema secondary to retinal vein occlusion usin optical coherence tomography and its correlation with visual acuity</description>
    <arm_group_label>Patients with macular edema due to RVO</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        in patients developing retinal vein occlusion for following up their changes in OCT &amp; VA
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with macular edema related to vein occlusion .

          -  Patient's Age above 18 years old .

          -  Patients able to sit on OCT device .

        Exclusion Criteria:

          -  Significant cataract .

          -  Media opacities as vitreous haemorrhage .

          -  patients with macular edema related to CRVO treated by laser photocoagulation .

          -  patients with glaucoma .

          -  Patients with chronic uveitis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdelsalam a Mohamed, ass. prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samir Y Saleh, professor</last_name>
    <phone>00201003304320</phone>
    <email>samir.abouelail@med.au.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>waleed s Mohamed, lecturer</last_name>
    <phone>002012223971491</phone>
    <email>walidibrahim72@aun.edu.eg</email>
  </overall_contact_backup>
  <reference>
    <citation>Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol. 1997 Apr;115(4):486-91. Erratum in: Arch Ophthalmol 1997 Oct;115(10):1275.</citation>
    <PMID>9109757</PMID>
  </reference>
  <reference>
    <citation>Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology. 1983 May;90(5):458-74.</citation>
    <PMID>6877778</PMID>
  </reference>
  <reference>
    <citation>Hayreh SS. Retinal vein occlusion. Indian J Ophthalmol. 1994 Sep;42(3):109-32. Review.</citation>
    <PMID>7829175</PMID>
  </reference>
  <reference>
    <citation>Williamson TH. Central retinal vein occlusion: what's the story? Br J Ophthalmol. 1997 Aug;81(8):698-704. Review.</citation>
    <PMID>9349161</PMID>
  </reference>
  <results_reference>
    <citation>Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994 Apr 15;117(4):429-41.</citation>
    <PMID>8154523</PMID>
  </results_reference>
  <results_reference>
    <citation>Moschos MM, Moschos M. Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study. Doc Ophthalmol. 2008 Mar;116(2):147-52. doi: 10.1007/s10633-007-9110-9. Epub 2008 Jan 10.</citation>
    <PMID>18189152</PMID>
  </results_reference>
  <results_reference>
    <citation>Gupta B, Grewal J, Adewoyin T, Pelosini L, Williamson TH. Diurnal variation of macular oedema in CRVO: prospective study. Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):593-6. doi: 10.1007/s00417-008-1011-4. Epub 2008 Dec 4.</citation>
    <PMID>19052771</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2018</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ali Omar Mohamed Ali</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Edema</mesh_term>
    <mesh_term>Retinal Vein Occlusion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

